MedTrace Logo

Effectiveness and Safety of Collagen Complex COLLOST in Anti-age Therapy

NCT03677258 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-09-19

No results posted yet for this study

Summary

This study evaluates the statistics of anti-age treatment in outpatient sites in Russia (involution indicators: clinical scales; instrumental diagnostics, ultrasonic scannings, assesment of allergic state, efficacy assesment in according with GAIS scale) in routine clinical practice with focus on collagen therapy.

Conditions

  • Skin Aging

Interventions

DEVICE

Collagen for injections 7%

Injection of medical device

DEVICE

Hyaluronic acid for injections 2%

Injection of medical device

Sponsors & Collaborators

  • Institute of Plastic Surgery and Cosmetology, Moscow, Russia

    collaborator UNKNOWN

  • Nearmedic Plus LLC

    lead INDUSTRY

Principal Investigators

  • Anna Stenko, PhD · Institute of Plastic Surgery and Cosmetology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-25
Primary Completion
2018-04-15
Completion
2018-07-08

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03677258 on ClinicalTrials.gov